Search

Your search keyword '"Marc H.A. Bemelmans"' showing total 3 results
Start Over Author "Marc H.A. Bemelmans" Journal hpb
3 results on '"Marc H.A. Bemelmans"'

1. Implementation and outcome of minor and major minimally invasive liver surgery in the Netherlands

Author

Moh'd Abu Hilal, Marcel J. van der Poel, Michael F. Gerhards, Marc H.A. Bemelmans, Wouter K. G. Leclercq, Andries E. Braat, Pieter J. Tanis, J. Sven D. Mieog, Marc G. Besselink, Pascal G. Doornebosch, Rutger-Jan Swijnenburg, Burak Görgec, Paul D. Gobardhan, Joost M. Klaase, Peter B. van den Boezem, Quintus Molenaar, Inne H.M. Borel Rinkes, Geert Kazemier, Cornelis H. C. Dejong, Jeroen Hagendoorn, Ronald M. van Dam, Türkan Terkivatan, Arjen M. Rijken, Koop Bosscha, S. J. Oosterling, Gerrit D. Slooter, Werner A. Draaisma, Wouter W. te Riele, Maarten Vermaas, Vincent B. Nieuwenhuijs, Petrousjka van den Tol, Christiaan Hoff, Hendrik A. Marsman, Marieke T. de Boer, Martijn W J Stommel, R. Fichtinger, Babs M Zonderhuis, Joost A B van der Hoeven, M. Liem, Carolijn L.M.A. Nota, Gijs A. Patijn, Daan J. Lips, Groningen Institute for Organ Transplantation (GIOT), Value, Affordability and Sustainability (VALUE), CCA - Cancer Treatment and quality of life, Surgery, AGEM - Re-generation and cancer of the digestive system, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, Graduate School, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, and CCA - Cancer Treatment and Quality of Life

Subjects
Liver surgery, Male, medicine.medical_specialty, RESECTION, Attitude of Health Personnel, Operative Time, Liver resections, RECOMMENDATIONS, Resection, 03 medical and health sciences, 0302 clinical medicine, Postoperative Complications, Robotic Surgical Procedures, Surveys and Questionnaires, Operating time, medicine, PROGRAM, Hepatectomy, Humans, Aged, Netherlands, Retrospective Studies, Surgeons, Hepatology, business.industry, Gastroenterology, Retrospective cohort study, Middle Aged, Conversion to Open Surgery, Surgery, MODEL, Multicenter study, Liver, 030220 oncology & carcinogenesis, Operative time, EXPERIENCE, 030211 gastroenterology & hepatology, Female, Laparoscopy, LEARNING-CURVE, business, Learning Curve, SYSTEM
Abstract

Background: While most of the evidence on minimally invasive liver surgery (MILS) is derived from expert centers, nationwide outcomes remain underreported. This study aimed to evaluate the implementation and outcome of MILS on a nationwide scale. Methods: Electronic patient files were reviewed in all Dutch liver surgery centers and all patients undergoing MILS between 2011 and 2016 were selected. Operative outcomes were stratified based on extent of the resection and annual MILS volume. Results: Overall, 6951 liver resections were included, with a median annual volume of 50 resections per center. The overall use of MILS was 13% (n = 916), which varied from 3% to 36% (P < 0.001) between centers. The nationwide use of MILS increased from 6% in 2011 to 23% in 2016 (P < 0.001). Outcomes of minor MILS were comparable with international studies (conversion 0–13%, mortality

Published
2019

2. Training, Implementation, and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate FLR Hypertrophy – First Worldwide DRAGON 1 Experience

Author

Christoph A. Binkert, B. Olij, C. van der Leij, R.M. van Dam, X. Wang, R. Korenblik, Marc H.A. Bemelmans, and Erik Schadde

Subjects
medicine.medical_specialty, medicine.anatomical_structure, Hepatology, business.industry, medicine.medical_treatment, Gastroenterology, medicine, Embolization, Vein, business, Muscle hypertrophy, Surgery
Published
2021

3. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience

Author

Ronald M. van Dam, Marc H.A. Bemelmans, Mechteld C. de Jong, Steven W.M. Olde Damink, Cornelis H. C. Dejong, Geerard L. Beets, Monique Maas, RS: NUTRIM - R2 - Gut-liver homeostasis, RS: GROW - School for Oncology and Reproduction, Surgery, and Beeldvorming

Subjects
Adult, Male, Oncology, medicine.medical_specialty, Time Factors, Colorectal cancer, Treatment sequence, Risk Assessment, Disease-Free Survival, Metastasis, Text mining, Risk Factors, Internal medicine, Carcinoma, Hepatectomy, Humans, Medicine, Prospective Studies, Colectomy, Aged, Netherlands, Aged, 80 and over, Chi-Square Distribution, Hepatology, business.industry, Liver Neoplasms, Gastroenterology, Chemoradiotherapy, Adjuvant, Original Articles, Middle Aged, medicine.disease, Survival Analysis, Neoadjuvant Therapy, Survival Rate, Single centre, Treatment Outcome, Chemotherapy, Adjuvant, Feasibility Studies, Female, Radiotherapy, Adjuvant, Colorectal Neoplasms, business, synchronous colorectal liver metastasis
Abstract

BACKGROUND: For patients who present with synchronous colorectal carcinoma and colorectal liver metastasis (CRLM), a reversed treatment sequence in which the CRLM are resected before the primary carcinoma has been proposed (liver-first approach). The aim of the present study was to assess the feasibility and outcome of this approach for synchronous CRLM. METHODS: Between 2005 and 2010, 22 patients were planned to undergo the liver-first approach. Feasibility and outcomes were prospectively evaluated. RESULTS: Of the 22 patients planned to undergo the liver-first strategy, the approach was completed in 18 patients (81.8%). The main reason for treatment failure was disease progression. Patients who completed treatment and patients who deviated from the protocol had a similar location of the primary tumour, as well as comparable size, number and distribution of CRLM (all P > 0.05). Post-operative morbidity and mortality were 27.3% and 0% following liver resection and 44.4% and 5.6% after colorectal surgery, respectively. On an intention-to-treat-basis, overall 3-year survival was 41.1%. However, 37.5% of patients who completed the treatment had developed recurrent disease at the time of the last follow-up. CONCLUSIONS: The liver-first approach is feasible in approximately four-fifths of patients and can be performed with peri-operative mortality and morbidity similar to the traditional treatment paradigm. Patients treated with this novel strategy derive a considerable overall-survival-benefit, although disease-recurrence-rates remain relatively high, necessitating a multidisciplinary approach.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results